Diabetes drug vs cholesterol meds: new battle for liver health
NCT ID NCT07180745
Summary
This study compares two types of medications—empagliflozin (a diabetes drug) and statins (cholesterol medications)—to see which works better for treating fatty liver disease. Researchers will enroll 400 adults who have fatty liver disease along with obesity, diabetes, and high cholesterol. Participants will take different combinations of these medications for three months while doctors measure changes in liver fat and stiffness using specialized scans and blood tests.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Teaching hospital of Beni Suef University
Banī Suwayf, 62727, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.